Overview
- New JAMA analyses found that colon cancer diagnoses among 45- to 49-year-olds jumped by about 12% per year from 2019 to 2022, driven largely by rises in localized tumor detection.
- Screening participation in this age group climbed 62% between 2019 and 2023 but only roughly one-third of eligible adults are up-to-date on recommended tests.
- Automatically mailing fecal immunochemical test kits to 45- to 49-year-olds achieved over 26% screening uptake, outperforming opt-in and patient-portal invitations under 20%.
- Early-stage detections confer a five-year survival rate of around 91%, reducing the need for more invasive treatments.
- HHS Secretary Robert F. Kennedy Jr.’s proposal to dissolve the U.S. Preventive Services Task Force could eliminate no-cost insurance coverage for these preventive screenings.